Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and may be useful for raising HDL-cholesterol and reducing LDL-cholesterol in human patients and for treating or preventing atherosclerosis.
具有I式结构的化合物,包括化合物的药学上可接受的盐,是CETP
抑制剂,可用于提高人类患者的HDL
胆固醇和降低LDL
胆固醇,以及用于治疗或预防动脉粥样硬化。